NCT05753982 is a NA clinical trial of Kinesiotape placement in Chest Wall Injury, sponsored by University Medical Centre Ljubljana.

Who is sponsoring NCT05753982?

NCT05753982 is sponsored by University Medical Centre Ljubljana.

What drugs are being tested in NCT05753982?

Interventions in NCT05753982: Kinesiotape placement.

What condition does NCT05753982 study?

NCT05753982 studies Chest Wall Injury.

Is NCT05753982 still recruiting?

NCT05753982 is currently completed. Last updated 6 February 2024.

Last reviewed 2024-02-06 · How we verify

NCT05753982

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Infuence of Kinesiotaping on Pulmonary Function Improvement in Multiple Rib Fracture

Completed NA Last updated 6 February 2024

What this trial tests

NA trial testing Kinesiotape placement in Chest Wall Injury in 40 participants. Completed in 31 January 2024.

Timeline

27 August 2022

Primary endpoint
31 January 2024

31 January 2024

Quick facts

Lead sponsor	University Medical Centre Ljubljana
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	40
Start date	27 August 2022
Primary completion	31 January 2024
Estimated completion	31 January 2024
Sites	1 location across Slovenia

Drugs / interventions tested

Kinesiotape placement

Conditions studied

Chest Wall Injury — all drugs for Chest Wall Injury →

Sponsor

University Medical Centre Ljubljana

Who can join

Adults 18 to 65, any sex, with Chest Wall Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Elastic tapes, named "kinesiotapes" have a limited, but proven influence on pain reduction, improvement in muscular strength and joint function. It can be hypothetised that by using kinesiotape techniques on damaged chest wall (due to mostly rib fracture) we can improve not only analgesia, but also improve lung function tests and speed recovery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University Medical Centre Ljubljana trials

Trials by the same sponsor.

NCT07466472 — Image-Guided Central Catheter Insertion With Concurrent Assessment of Vascular Wall Integrity · not yet recruiting
NCT07446244 — Catheter Ablation of Advanced Forms of Atrial Fibrillation · NA · enrolling by invitation
NCT07109076 — Effect of Immediate Skin-to-Skin Contact on Neonatal Heart Rate Variability After Cesarean Secton · NA · recruiting
NCT07354880 — Effect of Tirzepatide on Cardiovascular and Metabolic Parameters in Obese Adult Patients With Congenital Heart Disease · Phase 4 · not yet recruiting
NCT07496736 — Post-exposure Influenza Prophylaxis in a Hospital Setting · Phase 3 · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05753982 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Medical Centre Ljubljana
Last refreshed: 6 February 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05753982.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing